Puig Brands S.A./ADR Business Summary

Puig Brands S.A. is a vertically integrated global powerhouse in the premium beauty and fashion sectors, generating revenue through the design, manufacture, and multi-channel distribution of high-margin luxury goods. The company operates through three primary business segments: Fragrance & Fashion, which accounts for approximately 73% of net revenue through iconic labels like Rabanne, Carolina Herrera, and Jean Paul Gaultier; Makeup, anchored by the high-growth Charlotte Tilbury brand; and Skincare, featuring dermo-cosmetic and prestige labels such as Uriage and Dr. Barbara Sturm. Puig utilizes a diversified distribution strategy spanning travel retail, prestige department stores, and a robust direct-to-consumer digital platform. Within the competitive landscape, Puig competes directly with L'Oréal Luxe, The Estée Lauder Companies, LVMH, and Coty, distinguishing itself as a specialized "brand builder" that prioritizes creative independence and long-term brand equity over the mass-market volume strategies of its larger peers. Founded in 1914 by Antonio Puig Castelló, the company remains under the strategic stewardship of the third generation of the Puig family. Marc Puig Guasch serves as Chairman and CEO, having led the firm's transformation from a regional distributor into a global luxury conglomerate. He is supported by Vice Chairman Manuel Puig Rocha and Deputy CEO José Manuel Albesa, a company veteran promoted in late 2025 to oversee all business divisions. The executive leadership also includes CFO Joan Albiol, who managed the company’s 2024 public listing, and COO Javier Bach. Despite its status as a publicly traded entity on the Spanish exchanges (ADR: PUGBY), the Puig family maintains definitive control, holding roughly 74% of the equity and 93% of the voting rights. The board of directors is further strengthened by independent industry veterans such as Lead Director Nicolas Mirzayantz and Daniel Lalonde, ensuring a balance of family heritage and institutional governance.